By 2029, new tuberculosis vaccines are expected to save more than seven million lives, emerging as a crucial element for global health improvement. Ensuring a steady supply for the countries most affected by the disease is essential. Additionally, these vaccines may provide considerable economic advantages for developing nations. Gavi aims to promote timely accessibility and widespread distribution of these immunizations.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.